Description
Research-Grade TB-500 Peptide | 10mg Lyophilised Powder
TB-500 10mg is a research-grade peptide supplied as a lyophilised powder for laboratory and scientific research applications. TB-500 is a synthetic peptide fragment associated with research into thymosin beta-4 pathways, cellular migration, tissue remodelling and regenerative biology.
For laboratory research use only. Not for human consumption.
TB-500 10mg Overview
TB-500 is a synthetic peptide commonly studied in research involving cellular repair and tissue-remodelling pathways. It is structurally related to a biologically active region of thymosin beta-4 (Tβ4), a naturally occurring peptide that has been investigated for its roles in cell migration, angiogenesis and tissue repair.
Research on thymosin beta-4 has explored its biological activity in wound-healing and tissue-repair models. However, findings involving full-length thymosin beta-4 should not automatically be interpreted as evidence for the safety or effectiveness of TB-500 itself.
TB-500 is therefore best approached as a research compound for controlled laboratory investigation, rather than as a therapeutic product.
What Is TB-500?
TB-500 is a synthetic peptide associated with a short sequence derived from thymosin beta-4. Research literature describes thymosin beta-4 as an actin-binding protein involved in cellular processes including cell movement and tissue-remodelling pathways.
Current research interest surrounding TB-500 includes investigations into:
- Cellular migration pathways
- Actin-related biological processes
- Tissue-remodelling mechanisms
- Regenerative biology
- Inflammation-related research models
- Cellular repair pathways
- Experimental wound-healing models
Importantly, research findings from thymosin beta-4 cannot automatically be transferred to TB-500. Scientific evaluation of the specific compound, formulation and experimental model remains necessary.
TB-500 Research Applications
TB-500 may be investigated in laboratory settings where researchers are studying biological pathways associated with tissue repair and cellular behaviour.
Cellular Research
TB-500-related research can be used to investigate cellular signalling, migration and other processes associated with tissue-remodelling biology.
Tissue-Repair Research
Thymosin beta-4 has been investigated in experimental wound-healing and tissue-repair models. These studies provide scientific context for continued research into related peptide pathways.
Actin and Cell-Migration Research
Thymosin beta-4 has an established relationship with actin, a major component of the cellular cytoskeleton. This makes the pathway relevant to studies examining cell structure and migration.
Regenerative Biology
Researchers have investigated thymosin beta-4-related pathways in areas including angiogenesis, inflammation and tissue regeneration. These findings remain an area of ongoing scientific investigation.
TB-500 10mg Product Specifications
| Specification | Details |
|---|---|
| Product | TB-500 |
| Quantity | 10mg |
| Form | Lyophilised powder |
| Product Type | Research peptide |
| Intended Use | Laboratory and scientific research |
| SKU | TB10 |
| Storage | Follow the product label and applicable laboratory storage requirements |
| Supplier | MediTech Plus Australia |
Why Choose MediTech Plus Australia?
MediTech Plus Australia focuses on research-use products and laboratory consumables for Australian researchers and laboratories.
Research-Focused Supply
Products are supplied for scientific and laboratory research rather than human therapeutic use.
Batch Documentation
Where available, product documentation and Certificate of Analysis information can help researchers review relevant batch information before laboratory use.
Australian Supply
MediTech Plus Australia provides research products for customers across Australia, subject to applicable regulatory requirements.
Professional Product Labelling
Clear product identification and specifications help researchers maintain accurate laboratory records and research workflows.
TB-500 and Thymosin Beta-4: What’s the Difference?
TB-500 and thymosin beta-4 are related but should not be treated as identical compounds.
Thymosin beta-4 is a naturally occurring 43-amino-acid peptide that has been investigated in a range of biological and clinical research contexts. TB-500 is generally described as a synthetic fragment or analogue associated with the thymosin beta-4 sequence.
Because the compounds are not identical, evidence relating to thymosin beta-4 should not automatically be considered evidence for TB-500. Researchers should evaluate studies based on the specific compound, formulation and experimental conditions involved.
Important Research Information
TB-500 products marketed online should not be represented as approved medicines or as products proven to treat, prevent or cure disease.
The Australian Therapeutic Goods Administration (TGA) states that unapproved peptide products, including products containing TB-500, have not been evaluated by the TGA for safety, quality or effectiveness.
The FDA has also identified limited safety information concerning TB-500-related substances and notes that important safety questions remain unresolved.
Accordingly, this product is supplied strictly for laboratory research purposes.
Frequently Asked Questions
What is TB-500 10mg?
TB-500 10mg is a research peptide supplied as a lyophilised powder. It is associated with research into thymosin beta-4-related cellular and tissue-remodelling pathways.
Is TB-500 the same as thymosin beta-4?
No. TB-500 and full-length thymosin beta-4 are related but are not identical compounds. Research findings for one should not automatically be applied to the other.
What is TB-500 used for in research?
Research involving TB-500 may examine cellular migration, tissue-remodelling mechanisms, actin-related processes and regenerative biology.
Is TB-500 approved for human use in Australia?
TB-500 is not an approved therapeutic product simply because it is available online. The TGA identifies TB-500 among unapproved peptide products and states that such products have not been evaluated for safety, quality or effectiveness.
Can TB-500 be used for injury recovery?
This product should not be promoted or used as a treatment for injury or other medical conditions. Research involving thymosin beta-4 has investigated tissue repair, but evidence relating to the full-length peptide does not establish TB-500 as a human treatment.
Is TB-500 intended for human consumption?
No. This product is supplied for laboratory research only and is not for human consumption.
Does the product include a Certificate of Analysis?
Where applicable, batch documentation may be available through MediTech Plus Australia’s Certificate of Analysis resources. Researchers should review available documentation and product specifications before using a research compound.
Research-Use Disclaimer
For Laboratory Research Use Only. Not for Human Consumption.
TB-500 10mg is supplied exclusively as a research-use product. It is not intended to diagnose, treat, cure or prevent any disease or medical condition. No information on this page should be interpreted as medical advice, dosing guidance or a recommendation for human use.
Researchers are responsible for ensuring that the acquisition, handling, storage and use of research compounds comply with applicable Australian laws, institutional requirements and laboratory safety procedures.
Order TB-500 10mg for Research
MediTech Plus Australia supplies research-grade peptide products for laboratory and scientific applications. TB-500 10mg is available in a 10mg lyophilised format for appropriately controlled research environments.
Research use only. Not for human consumption.
📅 Last updated:
Reviews
There are no reviews yet.